Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: LUMIRADX, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-30 to 2022-05-31
Current total value of award: $5240000
Description: EO14042 AWARD A CONTRACT FOR RADX TECH - LUMIRADX SHALL PROVIDE A SARS-COV-2 & FLU A/B HIGH SENSITIVITY AG ASSAY